; and (2) the needs of the States, as determined based on the populations of each State. (c) Funding Amounts available in the Defense Production Act Fund under section 304 of the Defense Production Act of 1950 ( 50 U.S.C. 4534 ) shall be available to carry out this section. (d) Termination (1) In general This section shall terminate on the date on which there are no remaining requests under subsection (b)(1). (2) Disposition of unused COVID–19 supplies Any COVID–19 supplies produced pursuant to subsection (a)(3)(A) using amounts from the Defense Production Act Fund and unused as of the date described in paragraph (1) shall be deposited in the Strategic National Stockpile under section 319F–2 of the Public Health Service Act ( 42 U.S.C. 247d–6b ), including any such supplies authorized for emergency use under section 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–3 ). (e) Definitions In this Act: (1) COVID–19 supples The term COVID–19 supplies includes— (A) personal protective equipment, including face shields, N–95 respirator masks, and any other masks determined by the Secretary of Health and Human Services to be needed to respond to the COVID–19 pandemic and the materials necessary to produce such personal protective equipment; (B) diagnostic tests for COVID–19 and the reagents and other materials necessary for producing or conducting such tests; and (C) any vaccine approved by the Food and Drug Administration to prevent COVID–19 and other materials necessary for producing and administering such vaccines. (2) State The term State includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, American Samoa, and the Commonwealth of the Northern Mariana Islands.